Open access · CC-BY
via OpenAlex
IGF-1R Inhibitor Ameliorates Neuroinflammation in an Alzheimer’s Disease Transgenic Mouse Model
Mona Sohrabi, Angela Marie Floden, Gunjan Dhawan Manocha, Marilyn G. Klug, Colin Kelly Combs
Frontiers in Cellular Neuroscience · 2020 · ▲ 49 citations
Abstract
Aging is a major risk factor for Alzheimer’s disease (AD). Insulin like growth factor-1 receptor (IGF-1R) regulates general aging and lifespan. However, the contribution of IGF-1 to age-related AD pathology and progression is highly controversial. Based on our previous work, AβPP/PS1 double transgenic mice, which express human mutant amyloid precursor protein (APP) and presenilin-1 (PS-1), demonstrated a decrease in brain IGF-1 levels when they were crossed with IGF-1 deficient Ames dwarf mice (df/df). Subsequently, a reduction in gliosis, amyloid-β (Aβ) plaque deposition, and Aβ1-40/42 concentrations were observed in this mouse model. This supported the hypothesis that IGF-1 may contribute to progression of disease. To assess the role of IGF-1 in AD, 9-10-month-old male littermate control wild type and AβPP/PS1 mice were randomly divided into 2 treatment groups including control vehicle (DMSO) and picropodophyllin (PPP), a selective, competitive, and reversible IGF-1R inhibitor. The brain penetrant inhibitor was given ip. at 1mg/kg/day. Mice were sacrificed after 7 days of daily injection and the brains, spleens, and livers were collected to quantify histologic and biochemical changes. The PPP-treated AβPP/PS1 mice demonstrated attenuated insoluble Aβ1-40/42 and pro-inflammatory cytokine levels in the temporal cortex including eotaxin, TNF-, IL-1, and IL-1. Additionally, an attenuation in microgliosis and protein p-tyrosine levels were observed due to drug treatment in the hippocampus. Our data suggests IGF-1R signaling is associated with disease progression in this mouse model. More importantly, modulation of the brain IGF-1R signaling pathway, even at mid-life, was enough to attenuate aspects of disease phenotype. This suggests that small molecule therapy targeting the IGF-1R pathway may be viable for late stage disease treatment.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fncel.2020.00200
- Canonical
- link ↗
- Fetched
- 2026-10-22 MST
Cite this
APA
Sohrabi, M., Floden, A.M., Manocha, G.D., Klug, M.G., & Combs, C.K. (2020). IGF-1R Inhibitor Ameliorates Neuroinflammation in an Alzheimer’s Disease Transgenic Mouse Model. <em>Frontiers in Cellular Neuroscience</em>. https://doi.org/10.3389/fncel.2020.00200
Vancouver
Sohrabi M, Floden AM, Manocha GD, Klug MG, Combs CK. IGF-1R Inhibitor Ameliorates Neuroinflammation in an Alzheimer’s Disease Transgenic Mouse Model. Frontiers in Cellular Neuroscience. 2020. doi:10.3389/fncel.2020.00200.
BibTeX
@article{mona2020IGFRIn,
title = {IGF-1R Inhibitor Ameliorates Neuroinflammation in an Alzheimer’s Disease Transgenic Mouse Model},
author = {Mona Sohrabi and Angela Marie Floden and Gunjan Dhawan Manocha and Marilyn G. Klug and Colin Kelly Combs},
journal = {Frontiers in Cellular Neuroscience},
year = {2020},
doi = {10.3389/fncel.2020.00200},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Neurochemistry 2005
Citation only
Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease
Neurobiology of Disease 2022
Open access · CC-BY
Alzheimer's disease/dementia-associated brain pathology in aging DPP6-KO mice
Aging 2019
Preprint · CC-BY
Telomerase gene therapy ameliorates the effects of neurodegeneration associated to short telomeres in mice
Frontiers in Cell and Developmental Biology 2020
Open access · CC-BY
A Healthy Heart and a Healthy Brain: Looking at Mitophagy
Journal of Neurochemistry 2000
Open access · OA
The Catalytic Subunit of Telomerase Protects Neurons Against Amyloid β‐Peptide‐Induced Apoptosis
bioRxiv (Cold Spring Harbor Laboratory) 2024
Preprint · CC-BY